Development of anti-TNF therapy for rheumatoid arthritis.
The aetiology of systemic, autoimmune, chronic inflammatory diseases--such as rheumatoid arthritis--is not known, and their pathogenesis is complex and multifactorial. However, progress in the characterization of intercellular mediators--proteins that are now known as cytokines--has led to the reali...
Yazar: | Feldmann, M |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2002
|
Benzer Materyaller
-
ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (1993) -
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
Yazar:: Taylor, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009) -
Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001) -
Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)